LifeMD, Inc. (LFMDP)

Every figure below is the company's own, as filed. Nothing is estimated and nothing is smoothed — a period the filing does not support is left blank rather than drawn. Quarters are the company's own, counted from its financial year ending 12-31. Amounts in USD.

Revenue TTM

0 70M 140M 210M Q3 '21: 78.4M Q4 '21: 92.9M Q1 '22: 103.7M Q2 '22: 111.9M Q3 '22: 118.3M Q4 '22: 119M Q1 '23: 123.1M Q2 '23: 128.6M Q3 '23: 135.8M Q4 '23: 152.5M Q1 '24: 163.6M Q2 '24: 178.3M Q3 '24: 192.9M Q4 '24: 153.6M Q1 '25: 160.3M Q2 '25: 158.7M Q3 '25: 165.6M Q4 '25: 167.2M Q1 '26: 166.4M Q2 '26: 164.7M Q4 '21 Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26

Gross Profit TTM

0 60M 120M 180M Q3 '21: 62M Q4 '21: 74.9M Q1 '22: 83.7M Q2 '22: 91.3M Q3 '22: 98.2M Q4 '22: 100.4M Q1 '23: 105.5M Q2 '23: 111.1M Q3 '23: 118.2M Q4 '23: 133.6M Q1 '24: 144.3M Q2 '24: 158.5M Q3 '24: 172.9M Q4 '24: 132.1M Q1 '25: 135.3M Q2 '25: 131.9M Q3 '25: 136.4M Q4 '25: 140.5M Q1 '26: 142M Q2 '26: 141.8M Q4 '21 Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26

Operating Income TTM

-75M -50M -25M 0 25M 50M 75M Q3 '21: -73M Q4 '21: -54.3M Q1 '22: -55.5M Q2 '22: -52.3M Q3 '22: -46.7M Q4 '22: -43.4M Q1 '23: -33.2M Q2 '23: -25.2M Q3 '23: -22.7M Q4 '23: -14.5M Q1 '24: -17.8M Q2 '24: -19.2M Q3 '24: -18.6M Q4 '24: -22.4M Q1 '25: -17.5M Q2 '25: -13.5M Q3 '25: -11.5M Q4 '25: -11.7M Q1 '26: -19.5M Q2 '26: -24.3M Q4 '21 Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26

Net Income TTM

-90M -60M -30M 0 30M 60M 90M Q3 '21: -75M Q4 '21: -60.9M Q1 '22: -62.6M Q2 '22: -58.8M Q3 '22: -51.7M Q4 '22: -45.5M Q1 '23: -36.2M Q2 '23: -30M Q3 '23: -28.8M Q4 '23: -20.6M Q1 '24: -23.4M Q2 '24: -23.5M Q3 '24: -22M Q4 '24: -23.2M Q1 '25: -16.7M Q2 '25: -11.4M Q3 '25: -10.5M Q4 '25: 14.4M Q1 '26: 5.7M Q2 '26: 201K Q4 '21 Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26

Cost of Revenue TTM

0 10M 20M 30M Q3 '21: 16.4M Q4 '21: 18M Q1 '22: 20M Q2 '22: 20.5M Q3 '22: 20.2M Q4 '22: 18.7M Q1 '23: 17.6M Q2 '23: 17.5M Q3 '23: 17.6M Q4 '23: 18.9M Q1 '24: 19.3M Q2 '24: 19.8M Q3 '24: 20M Q4 '24: 21.4M Q1 '25: 25M Q2 '25: 26.8M Q3 '25: 29.2M Q4 '25: 26.6M Q1 '26: 24.4M Q2 '26: 22.9M Q4 '21 Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26

Operating Cash Flow TTM

-45M -30M -15M 0 15M 30M 45M Q3 '21: -33.8M Q4 '21: -33.1M Q1 '22: -32.1M Q2 '22: -31.4M Q3 '22: -26.8M Q4 '22: -22.9M Q1 '23: -17.5M Q2 '23: -2.7M Q3 '23: 1.1M Q4 '23: 8.8M Q1 '24: 16.6M Q2 '24: 16.5M Q3 '24: 22.2M Q4 '24: 17.5M Q1 '25: 15.4M Q2 '25: 19.5M Q3 '25: 12.6M Q4 '25: 8.3M Q1 '26: 5.7M Q2 '26: -9.9M Q4 '21 Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26

Free Cash Flow TTM

-45M -30M -15M 0 15M 30M 45M Q2 '22: -32M Q3 '22: -27.3M Q4 '22: -23.3M Q1 '23: -17.6M Q2 '23: -2.8M Q3 '23: 1.1M Q4 '23: 8.6M Q1 '24: 16.3M Q2 '24: 15.6M Q3 '24: 20.8M Q4 '24: 16M Q1 '25: 14M Q2 '25: 17.9M Q3 '25: 10.7M Q4 '25: 6.4M Q1 '26: 3.8M Q2 '26: -11.1M Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26

Operating cash flow minus capital expenditure.

Shares Outstanding Quarterly

0 20M 40M 60M Q1 '20: 10.7M Q2 '20: 12.3M Q3 '20: 14.7M Q1 '21: 24.5M Q2 '21: 26.3M Q3 '21: 26.7M Q1 '22: 30.9M Q2 '22: 30.8M Q3 '22: 30.9M Q1 '23: 31.7M Q2 '23: 32.6M Q3 '23: 34.5M Q1 '24: 39.2M Q2 '24: 41.3M Q3 '24: 42M Q1 '25: 43.1M Q2 '25: 44.4M Q3 '25: 46.2M Q1 '26: 47.3M Q2 '26: 47.8M Q2 '20 Q2 '21 Q2 '22 Q2 '23 Q2 '24 Q2 '25 Q2 '26

Weighted average diluted, as the filer reports it for each period. An average cannot be added across periods, so this one is always shown per period the filer tagged rather than as a trailing year.

EPS TTM

-0.08 -0.05 -0.03 0.00 0.03 0.05 0.08 Q4 '12: -0.03 Q1 '13: -0.03 Q2 '13: -0.02 Q1 '14: 0.00 Q2 '14: 0.00 Q3 '14: 0.00 Q4 '14: -0.01 Q1 '17: -0.06 Q2 '17: -0.03 Q3 '17: -0.04 Q4 '17: -0.04 Q4 '12 Q2 '13 Q2 '14 Q4 '14 Q2 '17 Q4 '17

The filer's own published earnings a share for each quarter, four quarters added up. The company page divides trailing net income by the share count instead, which lands within about 1% of this and is not the same sum, so the two are named differently rather than presented as one figure.